Medication info
Dongsung Rosuvastatin Tablets 10 mg (Rosuvastatin Calcium)

Dongsung Rosuvastatin Tablets 10 mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Dongsung Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets (15 tablets/PTP (AluAlu) * 2)
Approval status
Active

MFDS item code 201803165 · Approved 2018.07.31 · Insurance code 643203010

Summary

Main use
Improves dyslipidemia, reduces the risk of cardiovascular disease, and inhibits the progression of atherosclerosis
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Before and during treatment with this medicine, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted as a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 mg once daily. 3. Elderly patients : No dosage adjustment is necessary. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this medicine at a dose of 20 mg to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Ethnicity : Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients.
Children's dosage
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goals for each patient. Dose adjustments should be made at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
Dongsung Pharmaceutical Co., Ltd.

Efficacy & effects

Improves dyslipidemia, reduces the risk of cardiovascular disease, and inhibits the progression of atherosclerosis

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • dysbetalipoproteinemia
  • elevated high-sensitivity C-reactive protein
  • hypertension
  • low HDL-cholesterol levels
  • smoking
  • family history of early coronary artery disease
View approved original text

This medication is used in conjunction with diet and exercise for patients with primary hypercholesterolemia and mixed dyslipidemia when not controlled by these methods. It is also used as an adjunct to diet in patients with homozygous familial hypercholesterolemia and dysbetalipoproteinemia. It lowers total cholesterol and LDL-cholesterol levels in patients with hypercholesterolemia and helps delay the progression of atherosclerosis. It is also suitable for pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia who meet certain criteria. This medication helps reduce the risk of cardiovascular diseases, especially associated with stroke, myocardial infarction, and revascularization procedures. Overall, it is used to improve cholesterol levels and manage cardiovascular health.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Before and during treatment with this medicine, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted as a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 mg once daily. 3. Elderly patients : No dosage adjustment is necessary. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this medicine at a dose of 20 mg to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Ethnicity : Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients.

Children's dosage

Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goals for each patient. Dose adjustments should be made at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For example, it should be avoided by those allergic to it, patients with severely impaired liver function, or those with muscle diseases. Women who are pregnant or breastfeeding, as well as fertile women who do not use appropriate contraception, should also avoid this medication. It may affect liver function, so individuals with a history of liver disease or those who consume alcohol heavily should consult their doctor before use and undergo regular liver function tests. If symptoms such as muscle pain or weakness occur, they should immediately inform healthcare professionals, and in severe cases, discontinuation of the medication may be necessary. Special caution is warranted for individuals with decreased kidney function, hypothyroidism, or a family history of muscle disease. The risk of side effects may increase when this medication is taken with certain drugs, so patients should inform healthcare professionals if they are taking other medications. Women who may become pregnant should use appropriate contraception while on this medication and should discontinue use immediately if pregnancy occurs. In case of overdose, as there is no specific antidote, immediate hospital treatment should be sought, and liver function and muscle-related tests should be performed. Dizziness may occur during the use of this medication, so caution is needed when driving or operating machinery. Finally, as this medication contains lactose, it should not be taken by patients with lactose intolerance.

Side effects

Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-induced erythroderma, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, elevated AST, joint pain, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, systemic pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. The recommended storage temperature is between 1 and 30 degrees Celsius at room temperature. Proper storage helps maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets (15 tablets/PTP (AluAlu) * 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.